Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)

China flag China · Delayed Price · Currency is CNY
9.60
+0.04 (0.42%)
Apr 29, 2026, 3:00 PM CST
-5.88%
Market Cap 12.82B
Revenue (ttm) 9.36B
Net Income (ttm) 941.60M
Shares Out 1.34B
EPS (ttm) 0.70
PE Ratio 13.62
Forward PE n/a
Dividend 0.30 (3.13%)
Ex-Dividend Date n/a
Volume 5,790,000
Average Volume 11,418,878
Open 9.53
Previous Close 9.56
Day's Range 9.53 - 9.63
52-Week Range 9.50 - 11.80
Beta 0.30
RSI 32.93
Earnings Date Apr 30, 2026

About SHA:600420

Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and develops, produce, and sell of pharmaceutical products in China. The company offers nifedipine controlled release tablets, penicillin industrial potassium salt, touboke yuekui granules/capsules, sodium cefuroxime for injection, D-7ACA, fermented products, milnacipran hydrochloride tablets, compound licorice tablets, and cefoperazone dispersible tablets; and cefuroxime axetil tablets, cefuroxime sodium for injection, cefaclor extended-release capsules, cefixime granules, and c... [Read more]

Sector Healthcare
Founded 1996
Employees 9,697
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600420
Full Company Profile

Financial Performance

In 2025, SHA:600420's revenue was 9.36 billion, a decrease of -14.39% compared to the previous year's 10.94 billion. Earnings were 941.60 million, a decrease of -13.11%.

Financial Statements

News

There is no news available yet.